Literature DB >> 25315987

Liver disease after hematopoietic cell transplantation in adults.

J P Norvell1.   

Abstract

Liver-related complications constitute a large component of the overall morbidity and mortality associated with hematopoietic cell transplantation. Affecting up to 80% of allogeneic HCT recipients, prompt recognition and treatment are essential. The differential diagnosis is broad and is best categorized by time of onset after transplantation. Early complications include drug-induced liver injury, sinusoidal obstruction syndrome, and graft-versus-host disease. Late complications include infectious sequelae, cirrhosis, and hepatic malignancies. Patients being considered for hematopoietic cell transplantation should be screened and evaluated for liver-related complications to help improve outcomes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25315987     DOI: 10.1016/j.trre.2014.08.001

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  5 in total

Review 1.  Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Authors:  Mitchell S Cairo; Kenneth R Cooke; Hillard M Lazarus; Nelson Chao
Journal:  Br J Haematol       Date:  2020-03-04       Impact factor: 6.998

2.  Drop of Butyrylcholinesterase Activity after Cyclophosphamide Conditioning as a Predictive Marker of Liver Transplant-Related Complications and Its Correlation with Transplant-Related Mortality in Pediatric Hematopoietic Stem Cell Recipients.

Authors:  Natalia Maximova; Giulia Caddeo; Davide Zanon; Alessandra Maestro; Roberto Simeone
Journal:  J Clin Med       Date:  2019-06-10       Impact factor: 4.241

Review 3.  Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD).

Authors:  Karen E Matsukuma; Dongguang Wei; Kai Sun; Rajendra Ramsamooj; Mingyi Chen
Journal:  J Gastrointest Oncol       Date:  2016-04

4.  Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.

Authors:  Ming-Wei Liu; Rong Liu; Hai-Yin Wu; Wei Zhang; Jing Xia; Min-Na Dong; Wen Yu; Qiang Wang; Feng-Mei Xie; Rui Wang; Yun-Qiao Huang; Chuan-Yun Qian
Journal:  Int J Mol Med       Date:  2016-09-23       Impact factor: 4.101

5.  Multiple spider angiomas in a patient with chronic hepatic graft-versus-host disease.

Authors:  Ying Gu; Kun Li; Xia Wu; Jian-Zhong Zhang
Journal:  Chin Med J (Engl)       Date:  2020-03-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.